Skip to main content
. 2020 Jun 4;13(2):195–202. doi: 10.3892/mco.2020.2063

Table III.

Univariate and multivariate analysis with respect to progression-free survival in 40 stage IV breast cancer patients.

  Univariate analysis Multivariate analysis
Parameters Hazard ratio 95% CI P-value Hazard ratio 95% CI P-value
Age, years
     ≤64 1.138 0.516-2.511 0.749      
     >64            
Menopausal status
     Premenopausal 2.209 0.515-9.478 0.286      
     Postmenopausal            
Degree of progression
     Bone or soft tissue 0.605 0.271-1.355 0.222      
     Visceral metastases            
TILs
     High 0.527 0.208-1.339 0.178      
     Low            
Ki67, %
     ≤14 1.049 0.391-2.815 0.925 1.578 0.540-4.610 0.405
     >14            
Response rate
     ORR 0.179 0.072-0.443 <0.001 0.048 0.011-0.199 <0.001
     Non-ORR            
LPBC
     Yes 0.158 0.037-0.680 0.013 0.058 0.010-0.333 0.001
     No            

CI, confidence interval; TILs, tumor-infiltrating lymphocytes; ORR, objective response rate; LPBC, lymphocyte-predominant breast cancer.